Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

336 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: results from 2 phase I studies.
Surmont V, Smit EF, de Jonge M, Aerts JG, Nackaerts K, Vernhout R, Gras J, Van Wijk A, Phernambucq EC, van Meerbeeck JP, Senan S, Kraaij CJ, Chouaki N, Praag J, van Klaveren RJ. Surmont V, et al. Among authors: van klaveren rj, van meerbeeck jp, van wijk a. Lung Cancer. 2010 Sep;69(3):302-6. doi: 10.1016/j.lungcan.2009.12.001. Epub 2010 Jan 22. Lung Cancer. 2010. PMID: 20096951 Clinical Trial.
Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group.
Postmus PE, Haaxma-Reiche H, Smit EF, Groen HJ, Karnicka H, Lewinski T, van Meerbeeck J, Clerico M, Gregor A, Curran D, Sahmoud T, Kirkpatrick A, Giaccone G. Postmus PE, et al. J Clin Oncol. 2000 Oct 1;18(19):3400-8. doi: 10.1200/JCO.2000.18.19.3400. J Clin Oncol. 2000. PMID: 11013281 Clinical Trial.
Chemotherapy for non-small-cell lung cancer.
van Meerbeeck JP, Legrand C, van Klaveren RJ, Giaccone G; EORTC Lung Cancer Group. van Meerbeeck JP, et al. Among authors: van klaveren rj. Lancet. 2001 Oct 13;358(9289):1271-2. doi: 10.1016/S0140-6736(01)06363-2. Lancet. 2001. PMID: 11675091 No abstract available.
Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma.
van Haarst JM, Baas P, Manegold Ch, Schouwink JH, Burgers JA, de Bruin HG, Mooi WJ, van Klaveren RJ, de Jonge MJ, van Meerbeeck JP. van Haarst JM, et al. Among authors: van klaveren rj, van meerbeeck jp. Br J Cancer. 2002 Feb 1;86(3):342-5. doi: 10.1038/sj.bjc.6600118. Br J Cancer. 2002. PMID: 11875695 Free PMC article. Clinical Trial.
A phase II EORTC study of temozolomide in patients with malignant pleural mesothelioma.
van Meerbeeck JP, Baas P, Debruyne C, Smit EF, van Klaveren RJ, Galdermans D, Lentz MA, Manegold C, Giaccone G; EORTC Lung Cancer Group. van Meerbeeck JP, et al. Among authors: van klaveren rj. Eur J Cancer. 2002 Apr;38(6):779-83. doi: 10.1016/s0959-8049(01)00428-2. Eur J Cancer. 2002. PMID: 11937311 Clinical Trial.
336 results